PT383 – Identity, Rage, Culture, and Venture Capital

Panel: Psychedelic VCs Reflect on 2022

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

Rick Doblin – The Balance at MAPS Between Public Benefit and...

Psychedelic Funding in 2022

Expanding ketamine’s horizons for rare neurological disorders

Psychedelics in the Public Markets: 2022

The Psychedelic Value Chain

Psychedelics Weekly – Client Data Concerns in Oregon, Hopeful Legalization in...

Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University...

Load more